NewsRx

Search our medical news database

Abbott

Abbott Testifies Before U.S. Congress on Role of Private Sector in Advancing Science Education

Published in Health Business Week, August 14th, 2009

In a hearing today of the U.S. House of Representatives Subcommittee on Research and Science Education, part of the larger Committee on Science and Technology, Abbott (NYSE:ABT) testified on its contributions as a private sector company in a multi-stakeholder, systems approach to improving kindergarten through 12th grade (K-12) science, technology, engineering and mathematics (STEM) education.

"At Abbott, we believe that one of the most valuable contributions we can make is providing students with access to our research and development facilities and our scientists, who engage one-on-one with students," said Kathy Pickus, division vice president, Global Citizenship and...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook